The U.S. Food and Drug Administration (FDA) recently granted approval to Lecanemab, the first Alzheimer’s disease treatment to win approval since the largely failed rollout of Aduhelm two years ago.
A new analysis by Cedars-Sinai investigators is furthering the scientific community’s understanding of COVID-19 immunity by showing that similar levels of COVID-19 antibodies are reached over an extended period of time in different population groups.
Cedars-Sinai Cancer is taking on the country’s leading cause of cancer-related death with a new Lung Cancer Screening Program designed to reach more patients, simplify the screening process, and provide fast access to follow-up care.
Investigators at Cedars-Sinai have created a unique and detailed molecular profile of endometriosis to help improve therapeutic options for the millions of women suffering from the disease.
The U.S. Food and Drug Administration is poised to make a decision on another new Alzheimer’s disease treatment this week, and experts from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available to explain how the drug works and which patients could benefit from the medication.
Peter Heeger, MD, Justin Steggerda, MD, Hirsh Trivedi, MD, and Lorenzo Zaffiri, MD, PhD, have all recently joined the Cedars-Sinai Comprehensive Transplant Center.
Still in the giving spirit as the new year begins? Consider giving blood.
Physicians across the nation are describing an increase in requests from women for permanent contraception. The anecdotal reports by clinicians come in the wake of the U.S. Supreme Court ruling that overturned Roe v. Wade, the constitutional right to abortion.
Buffalo Bills safety Damar Hamlin, 24, remains hospitalized in "critical condition" after experiencing cardiac arrest when he collapsed mid-game against the Cincinnati Bengals on Monday night.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a recognition awarded to select U.S. medical centers that have a record of superior clinical outcomes resulting from evidence-based, guideline-directed degenerative mitral valve repair.
The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of Cardiology: interventional cardiologist Aakriti Gupta, MD, electrophysiologists Eric Braunstein, MD, and Archana Ramireddy, MD, and adult congenital cardiologist Prashanth Venkatesh, MD.
Two Cedars-Sinai physician organizations—Cedars-Sinai Medical Group and Cedars-Sinai Health Associates—have earned the highest honor bestowed by the Integrated Healthcare Association for demonstrating exceptional outcomes in quality, cost and patient experience.
In a new study evaluating the Mediterranean diet and adverse pregnancy outcomes, investigators from the Smidt Heart Institute at Cedars-Sinai found that women who conceived while adhering to the anti-inflammatory diet had a significantly lower risk of developing preeclampsia during pregnancy.
Less than three years after joining the Cedars-Sinai Cancer faculty, hematologist-oncologists Justin Darrah, MD, and Akil Merchant, MD, are pioneering new research and bringing a new, comprehensive set of treatment options to patients in the recently established Lymphoma Program.
Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells—cells that control your heartbeat—can “fight back” against therapies to biologically correct abnormal heartbeat rates.
The Pulmonary Fibrosis Foundation has named Cedars-Sinai part of its Care Center Network, a group of medical centers that have demonstrated expertise in treating and supporting people with this deadly disease.
Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when she was surprised to hear that a cardiologist was asked to come into the exam room.
Cedars-Sinai aortic aneurysm expert Ali Azizzadeh, MD is available for interviews about the telltale signs, risk factors and available treatment options for aortic aneurysms, a rare but often fatal condition.
When the holidays roll around at Cedars-Sinai Marina del Rey Hospital, so does a festive spiritual care cart pushed by Chaplain Hannah Rhiza, MDiv, BCC. Trimmed with sweets, fruit and lights, the cart brings Christmas, Kwanzaa and Hanukkah to hospital staff members where they work.
Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.
Clive Svendsen, PhD, a pioneer in regenerative medicine, has been awarded the Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing, from the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, for his impactful scientific work being done in amyotrophic lateral sclerosis (ALS).
Physician-scientists from Cedars-Sinai Cancer will present research and are available for comment on breaking news throughout the American Society of Hematology Annual Meeting & Exposition taking place Dec. 10-13 in New Orleans.
Investigators at Cedars-Sinai conduct more than 2,500 research projects annually, and many of these studies have resulted in new treatments or have opened the door to future innovations.
Physician-scientists from Cedars-Sinai Cancer are available for comment on research being presented throughout the San Antonio Breast Cancer Symposium, taking place Dec. 6-10.
Cedars-Sinai has earned the highest possible designation in U.S. News & World Report’s newly released list of “Best Hospitals for Maternity Care 2022-2023.” The medical center was rated “High Performing” for its care of patients during uncomplicated pregnancy and childbirth.
Women with prolonged mental health problems up to three years after childbirth may be suffering from irregular immune system responses, according to new research by Cedars-Sinai investigators. The findings are published in the American Journal of Reproductive Immunology.
A new theory suggests irritable bowel syndrome (IBS), the most common gastrointestinal disorder, may be caused by gravity.
A roundup of the latest research discoveries and faculty news at Cedars-Sinai.
Cedars-Sinai Pharmacy experts will present their latest advances in research and care in person at the midyear clinical meeting of the American Society of Health-System Pharmacists (ASHP) in Las Vegas Dec. 4-8, sharing innovations to improve medication safety, availability and effectiveness for hospital patients.
With COVID-19 and flu cases rising, and RSV (respiratory syncytial virus) affecting many young children, experts are bracing for a “tripledemic” of respiratory viruses this holiday season.
An initiative developed by Cedars-Sinai investigators improves the timeliness of treatment for women with severe pregnancy-related hypertension, one of the leading causes of pregnancy-related death.
The Smidt Heart Institute at Cedars-Sinai has selected board-certified cardiothoracic surgeon Tyler Gunn, MD, to be the director of the Extracorporeal Membrane Oxygenation, or ECMO, Program in the Department of Cardiac Surgery.
Sam Torbati, MD, co-chair and medical director of the Cedars-Sinai Ruth and Harry Roman Emergency Department, has been named the Levin-Gordon Chair in Emergency Medicine in Honor of Joel M. Geiderman, MD.
Bert Mandelbaum, MD, medical director of the FIFA Medical Center of Excellence, Cedars-Sinai Kerlan-Jobe Institute, and associate chief medical officer of Major League Soccer, has been providing medical care to the U.S men’s national soccer team for nearly three decades.
Nearly 1 in 7 Americans experience bloating on a weekly basis, and most aren’t seeking professional care for it, according to a new study led by Cedars-Sinai investigators. The findings are published in Clinical Gastroenterology and Hepatology.
The Smidt Heart Institute at Cedars-Sinai announces the expansion of its faculty in both vascular and cardiac surgery.
This Thanksgiving, when the Moraleses think about what they’re thankful for, the Thompsons are at the top of the list.
Experts from the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedars-Sinai are available for interviews and to comment on research being presented at the conference.
This holiday season, millions of people will be celebrating with family and friends. Preparing and sharing food is often the centerpiece of getting together. However, while good cheer may fill the air, danger could be lurking just beyond the door to the kitchen or dining room.
A study published this week in the Journal of the American College of Cardiology (JACC) found that seven major cardiovascular societies were more likely to distribute awards to men and white individuals when compared to women and those who identify as Asian, Hispanic/Latino, and Black.
For many high school football athletes who play on teams in underserved communities, access to athletic trainers or a licensed physician is a rarity but Cedars-Sinai Kerlan-Jobe Institute Surgeon and Team HEAL (Helping Enrich Athletes' Lives) Founder, Clarence Shields Jr., MD, has been working on a prescription to even that playing field.
A new study by Cedars-Sinai investigators describes risk factors that could make it more likely for people who have chronic pancreatitis, an ongoing inflammation of the pancreas, to develop diabetes. The findings are published in Diabetes Care.
Diabetes is a chronic health condition that impacts how the body turns food into energy. More than 37 million people in the United States have Type 2 diabetes, the most common form of the metabolic disorder, according to the Centers for Disease Control and Prevention. An additional 96 million adults have prediabetes and most of them are unaware they are developing a serious chronic disease.
In a study of pregnant women in the United States, Cedars-Sinai investigators found that a specific imbalance of two placental proteins could predict which women were at risk of developing a severe form of preeclampsia, a life-threatening blood pressure disorder.
De acuerdo a un nuevo análisis dirigido por investigadores de Cedars-Sinai y llevado a cabo en tres grandes sistemas de salud, el control y manejo de la hipertensión empeoraron durante los primeros meses de la pandemia de COVID-19.
The commercials said that if you joined, you could “Live the adventure.” They were for the U.S. Navy, and Gregory Jones, 16, took note.
November is Pancreatic Cancer Awareness Month as well as National Lung Cancer Awareness Month, and experts from Cedars-Sinai Cancer are available to discuss the newest research and treatment options.
Neuroscientists from Cedars-Sinai will present—and are available to comment on—cutting-edge brain research at the sixth International Human Single Neuron Meeting Nov. 10-11 at UCLA, and Neuroscience 2022, the annual meeting of the Society for Neuroscience, Nov. 12-16 in San Diego.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
